- Home
- Clinical Trials
Chronic Kidney Disease Studies Auckland
Canary Chronic Kidney Disease Study
Auckland
Chronic kidney disease (CKD) related to type 2 diabetes can progress over time and impact your long-term health. If you have stage 2–4 CKD and are on stable treatment, you may be eligible to take part in a clinical research study investigating a potential new injectable treatment.
By participating, you’ll receive regular kidney health monitoring, study-related medical care, and the opportunity to contribute to research that may help improve future treatment options for people with chronic kidney disease.
Description
What to expect
Study details
Ages
18-75 years of age
Duration
Approximately 30 weeks, with up to 9 in-clinic visits
Compensation
All eligible participants will be reimbursed for their time and travel costs
Eligibility Criteria
Eligibility Criteria
- You may qualify if you:
- Are 18-75 years of age
- Have stage 2-4 chronic kidney disease resulting from type 2 diabetes
- Have been on stable standard treatments, but continue to have signs of kidney damage
- Other eligibility criteria will be discussed by the research doctor
Locations
Description
Chronic Kidney Disease occurs when the kidneys gradually lose their ability to filter waste from the blood. In people with type 2 diabetes, damage to the kidney’s blood vessels can lead to ongoing inflammation and progressive kidney dysfunction. Living with chronic kidney disease is about more than managing a medical condition. It can affect many areas of life — from physical health to emotional wellbeing and everyday routines. For many people, the challenges of CKD aren’t always visible, but they are felt every day. While current treatments can slow progression, they don’t work for everyone.
This study is evaluating an investigational injectable medication designed to help stabilise blood vessels in the kidneys and reduce inflammation. The study compares the investigational medication with a placebo, and all participants are closely monitored throughout.
What to expect
Participants will be randomly assigned to receive either the study medication or a placebo (an inactive substance) via multiple subcutaneous injections (under the skin). During the study, participants will receive ongoing health monitoring and assessments with our professional medical team.
Your involvement in this study may help advance scientific knowledge that could contribute to the development of a new medication and better treatment for people with the same disease in the future.
Other reasons to participate include:
- Close health monitoring by highly experienced NZ doctors and nurses
- Study-related care is provided at no cost
- Reimbursement for time and travel costs
Register your interest to see if you're eligible today.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research NZ is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.